Literature DB >> 26648637

Managing osteoarthritis.

Shirley P Yu1, David J Hunter2.   

Abstract

Management of osteoarthritis should be based on a combination of non-drug and drug treatments targeted towards prevention, modifying risk and disease progression. Obesity is the most important modifiable risk factor, so losing weight in addition to land- and water-based exercise and strength training is important. While paracetamol can be tried, guidelines recommend non-steroidal anti-inflammatory drugs as first-line treatment for osteoarthritis. If there are concerns about the adverse effects of oral treatment, particularly in older patients or those with comorbidities, topical non-steroidal anti-inflammatory drugs can be used. Glucosamine does not appear to be any better than placebo for pain. Its effect on the structural progression of disease when taken alone or in combination with chondroitin is uncertain. Fish oil has not been found to reduce the structural progression of knee arthritis. Surgical interventions should be avoided in the first instance, with arthroscopic procedures not showing benefit over sham procedures or optimised physical and medical therapy. Joint replacement surgery should be considered for severe osteoarthritis.

Entities:  

Keywords:  capsaicin; chondroitin; glucosamine; non-steroidal anti-inflammatory drugs; opioids; osteoarthritis; paracetamol

Year:  2015        PMID: 26648637      PMCID: PMC4653978          DOI: 10.18773/austprescr.2015.039

Source DB:  PubMed          Journal:  Aust Prescr        ISSN: 0312-8008


  50 in total

1.  A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis.

Authors:  Philip G Conaghan; John Dickson; Wolfgang Bolten; Gregor Cevc; Matthias Rother
Journal:  Rheumatology (Oxford)       Date:  2013-03-28       Impact factor: 7.580

Review 2.  Lower extremity osteoarthritis management needs a paradigm shift.

Authors:  David J Hunter
Journal:  Br J Sports Med       Date:  2011-02-06       Impact factor: 13.800

Review 3.  Nutritional interventions to prevent and treat osteoarthritis. Part I: focus on fatty acids and macronutrients.

Authors:  Hector L Lopez
Journal:  PM R       Date:  2012-05       Impact factor: 2.298

4.  OARSI guidelines for the non-surgical management of knee osteoarthritis.

Authors:  T E McAlindon; R R Bannuru; M C Sullivan; N K Arden; F Berenbaum; S M Bierma-Zeinstra; G A Hawker; Y Henrotin; D J Hunter; H Kawaguchi; K Kwoh; S Lohmander; F Rannou; E M Roos; M Underwood
Journal:  Osteoarthritis Cartilage       Date:  2014-01-24       Impact factor: 6.576

5.  Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events.

Authors:  Andrew T Chan; JoAnn E Manson; Christine M Albert; Claudia U Chae; Kathryn M Rexrode; Gary C Curhan; Eric B Rimm; Walter C Willett; Charles S Fuchs
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

6.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Authors:  Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

Review 7.  Oral or transdermal opioids for osteoarthritis of the knee or hip.

Authors:  Eveline Nüesch; Anne Ws Rutjes; Elaine Husni; Vivian Welch; Peter Jüni
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

8.  Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.

Authors:  Elham Rahme; Alan Barkun; Hacene Nedjar; Sabine Gaugris; Douglas Watson
Journal:  Am J Gastroenterol       Date:  2008-03-26       Impact factor: 10.864

Review 9.  The future of osteoarthritis therapeutics: emerging biological therapy.

Authors:  A Mobasheri
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

10.  Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.

Authors:  Jean-Yves Reginster; Janusz Badurski; Nicholas Bellamy; William Bensen; Roland Chapurlat; Xavier Chevalier; Claus Christiansen; Harry Genant; Federico Navarro; Evgeny Nasonov; Philip N Sambrook; Timothy D Spector; Cyrus Cooper
Journal:  Ann Rheum Dis       Date:  2012-11-01       Impact factor: 19.103

View more
  14 in total

1.  Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.

Authors:  Vibeke Strand; Martin Bergman; Jasvinder A Singh; Allan Gibofsky; Alan Kivitz; Clarence Young
Journal:  Clin Rheumatol       Date:  2017-02-13       Impact factor: 2.980

2.  The lncRNA MIAT/miR-181a-5p axis regulates osteopontin (OPN)-mediated proliferation and apoptosis of human chondrocytes in osteoarthritis.

Authors:  Suolin Zeng; Min Tu
Journal:  J Mol Histol       Date:  2022-03-14       Impact factor: 2.611

3.  Effects of medications on incidence and risk of knee and hip joint replacement in patients with osteoarthritis: a systematic review and meta-analysis.

Authors:  Beibei Cui; Yuehong Chen; Yunru Tian; Huan Liu; Yupeng Huang; Geng Yin; Qibing Xie
Journal:  Adv Rheumatol       Date:  2022-06-27

4.  A Comprehensive Update of Prolotherapy in the Management of Osteoarthritis of the Knee.

Authors:  Alex Tang Zhao; Cassidy J Caballero; Linh T Nguyen; Hunter C Vienne; Christopher Lee; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2022-05-31

5.  Return to Work Following Isolated Opening Wedge High Tibial Osteotomy.

Authors:  Avinesh Agarwalla; David R Christian; Joseph N Liu; Grant H Garcia; Michael L Redondo; Adam B Yanke; Brian J Cole
Journal:  Cartilage       Date:  2019-06-10       Impact factor: 4.634

6.  A Fatal Sepsis Caused by Hyaluronate Knee Injection: How Much the Medical History and the Informed Consent Might Be Important?

Authors:  F Manfreda; G Rinonapoli; A Nardi; P Antinolfi; A Caraffa
Journal:  Case Rep Orthop       Date:  2017-02-23

7.  Editorial: One Step at a Time: Advances in Osteoarthritis.

Authors:  Ali Mobasheri; Troy N Trumble; Christopher R Byron
Journal:  Front Vet Sci       Date:  2021-07-16

Review 8.  Therapeutic potential of mesenchymal stem cell based therapy for osteoarthritis.

Authors:  John Burke; Monte Hunter; Ravindra Kolhe; Carlos Isales; Mark Hamrick; Sadanand Fulzele
Journal:  Clin Transl Med       Date:  2016-08-10

9.  MicroRNA-9 regulates the development of knee osteoarthritis through the NF-kappaB1 pathway in chondrocytes.

Authors:  Ronghe Gu; Ning Liu; Simin Luo; Weiguo Huang; Zhengang Zha; Jie Yang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

10.  Identification and Characterization of the Intra-Articular Microbiome in the Osteoarthritic Knee.

Authors:  Joseph C Tsai; Grant Casteneda; Abby Lee; Kypros Dereschuk; Wei Tse Li; Jaideep Chakladar; Alecio F Lombardi; Weg M Ongkeko; Eric Y Chang
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.